Influences of Artificial Heart-Lung Machine Operation on the Binding Sites of Albumin: Possibility of an Effective Administration Plan

Author:

Totoribe Kazuhiro12,Takamura Norito3,Ogata Kenji3,Tokunaga Jin3,Kawai Keiichi4,Nakamura Kunihide5,Ieiri Ichiro2,Higuchi Shun2

Affiliation:

1. Department of Pharmacy, Miyazaki Prefectural Nobeoka Hospital, Miyazaki - Japan

2. Department of Clinical Pharmacokinetics, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka - Japan

3. Second Department of Clinical Pharmacy, Graduate School of Clinical Pharmacy, Kyushu University of Health and Welfare, Miyazaki - Japan

4. Faculty of Health Sciences, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Ishikawa - Japan

5. Department of Cardiovascular Surgery, Miyazaki Prefectural Nobeoka Hospital, Miyazaki - Japan Currently Department of Surgery 2, Faculty of Medicine, University of Miyazaki, Miyazaki - Japan

Abstract

Purpose The purpose of this study is to investigate the influence of changes in the human serum albumin (HSA) and free fatty acid (FFA) on alteration of the binding abilities of sites I and II after the operation of an artificial heart-lung machine. Methods The binding abilities of phenytoin (site I) and diazepam (site II) to patients’ sera collected before and after the operation of an artificial heart-lung machine and pseudopatient serum samples were examined by ultra-filtration. Results The binding ability of site I markedly decreased after the operation of an artificial heart-lung machine in all patients, and the binding ability of site II unexpectedly increased in some patients. The variation in pseudopatient serum was similar to that in the patient sera. Conclusions The difference in the binding ability between sites I and II was due to that the fact that the binding ability of site I is more strongly influenced by HSA level reduction than by [FFA]/[HSA] reduction, whereas the binding ability of site II is more strongly influenced by [FFA]/[HSA] reduction than by HSA level reduction in some patients. Therefore, it may be possible to predict the binding ability of site I by monitoring the HSA level without directly monitoring the free phenytoin fraction (%).

Publisher

SAGE Publications

Subject

Biomedical Engineering,Biomaterials,General Medicine,Medicine (miscellaneous),Bioengineering

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3